Literature DB >> 31593813

In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetes.

Priyanka Sharma1, Tushar Joshi2, Tanuja Joshi3, Subhash Chandra4, Sushma Tamta5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Phyllanthus emblica Linn. (Syn. Emblica officinalis Gaertn.), has been used to cure many ailments of human beings. Literature survey demonstrates that it has many pharmacological activities i.e. antidiabetic, antioxidant, anti-microbial, antifungal, antiallergic, antiviral, and anticancer properties. AIM OF THE STUDY: The present study aimed to identify the novel plant-derived antidiabetic compounds from P. emblica to understand the molecular basis of antidiabetic activities.
MATERIAL AND METHODS: Text mining analysis of P. emblica and its disease association was carried out using server DLAD4U. Due to the highest score of P. emblica with diabetes, the virtual screening of a phytochemical library of P. emblica against three targets of diabetes was carried out. After that FAF-Drug4, admetSAR and DruLiTo servers were used for drug-likeness prediction. Additionally, pharmacophore modeling was also carried out to understand the antidiabetic activity of screened compounds.
RESULTS: The docking scores, drug-likeness and pharmacophore studies found that Ellagic acid, Estradiol, Sesamine, Kaempferol, Zeatin, Quercetin, and Leucodelphinidin are potential antidiabetic compounds.
CONCLUSIONS: Our study shows that phytochemicals of P. emblica are very potential antidiabetic candidates. Using the modern techniques these molecules could be used to develop an effective antidiabetic drugs from a natural resource.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Docking; Drug; Inhibitors; Phyllanthus emblica; Phytochemicals; Therapeutic targets; Type 2 diabetes (T2D)

Mesh:

Substances:

Year:  2019        PMID: 31593813     DOI: 10.1016/j.jep.2019.112268

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  Potential effect of tropical fruits Phyllanthus emblica L. for the prevention and management of type 2 diabetic complications: a systematic review of recent advances.

Authors:  Hao-Zhou Huang; Min Qiu; Jun-Zhi Lin; Meng-Qi Li; Xi-Tao Ma; Fei Ran; Chuan-Hong Luo; Xi-Chuan Wei; Run-Chun Xu; Peng Tan; San-Hu Fan; Ming Yang; Li Han; Ding-Kun Zhang
Journal:  Eur J Nutr       Date:  2021-01-13       Impact factor: 5.614

Review 2.  Antidiabetic Potential of Plants from the Caribbean Basin.

Authors:  Vanessa Méril-Mamert; Alejandro Ponce-Mora; Muriel Sylvestre; Genica Lawrence; Eloy Bejarano; Gerardo Cebrián-Torrejón
Journal:  Plants (Basel)       Date:  2022-05-20

Review 3.  Advances in biotechnology of Emblica officinalis Gaertn. syn. Phyllanthus emblica L.: a nutraceuticals-rich fruit tree with multifaceted ethnomedicinal uses.

Authors:  Saikat Gantait; Manisha Mahanta; Soumen Bera; Sandeep Kumar Verma
Journal:  3 Biotech       Date:  2021-01-11       Impact factor: 2.406

4.  Growth promotion and protective potentials of leaf infusions of Parkia biglobosa, Moringa oleifera and Vernonia amygdalina on Abelmoschus esculentus seeds.

Authors:  Oghenerobor B Akpor; Marvellous-Mercy Maxwell; Ikponmwosa O Evbuomwan; Tomilola D Olaolu; Abigail G Adeyonu; Omorefosa O Osemwegie
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

5.  Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies.

Authors:  Neeraj Choudhary; Gopal L Khatik; Rekha Sharma; Navneet Khurana; Richard Lobo; Shvetank Bhatt; Devesh Tewari; Ashish Suttee
Journal:  3 Biotech       Date:  2021-06-02       Impact factor: 2.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.